Back
CRISPR Therapeutics AG Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
CRSP
CRISPR Therapeutics AG
Last Price:
$55.02
Seasonality Move:
-17.77%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.77 | Sell |
| 20-day SMA: | 50.66 | Buy |
| 50-day SMA: | 43.14 | Buy |
| 200-day SMA: | 43.53 | Buy |
| 8-day EMA: | 54.69 | Buy |
| 20-day EMA: | 51.16 | Buy |
| 50-day EMA: | 44.22 | Buy |
| 200-day EMA: | 23.38 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.98 | Buy |
| Relative Strength Index (14 RSI): | 63.35 | Buy |
| Chaikin Money Flow: | 2664853 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.17 - 54.59) | Buy |
| Bollinger Bands (100): | (35.36 - 47.72) | Buy |
CRISPR Therapeutics AG Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 55.14 while CRSP 8-day simple moving average is 55.77, which is a Sell signal.
-
The stock price of CRSP is 55.14 while CRISPR Therapeutics AG 20-day SMA is 50.66, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 43.14 while CRSP share price is 55.14, making it a Buy technically.
-
CRSP stock price is 55.14 and CRISPR Therapeutics AG 200-day simple moving average is 43.53, creating a Buy signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
39
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $55.14. The Score for CRSP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.8B
Price in USD:
55.14
Share Volume:
3.3M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
63.39
52-Week Low:
30.04
Sell
39
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 55.14 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 55.14 while CRSP 8-day exponential moving average is 54.69, which is a Buy signal.
-
The stock price of CRSP is 55.14 while CRISPR Therapeutics AG 20-day EMA is 51.16, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 44.22 while CRSP share price is 55.14, making it a Buy technically.
-
CRSP stock price is 55.14 and CRISPR Therapeutics AG 200-day simple moving average is 23.38, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.23 per share, and an increase next year of $0.86 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 3.98, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 63.35, which suggest CRISPR Therapeutics AG is overbought
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (43.17 - 54.59), which suggest CRISPR Therapeutics AG is a Buy
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (35.36 - 47.72), which suggest CRISPR Therapeutics AG is a Buy
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.